関連する実験動画
Updated: Aug 16, 2026

11:59
In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
Published on: April 28, 2023
まとめ
高用量の静脈注射フェニトインナトリウムは,妊娠前出血症および妊娠後出血症患者の抗予防を効果的に提供しました. この治療は,治療用プラズマフェニトイン濃度が研究期間中に維持された良好な安全性プロファイルを示した.
科学分野:
- 産婦人科と産婦人科を担当しています.
- 薬理学 薬理学とは
- 神経学 神経学とは
背景:
- 妊娠前出血症と出血症は,妊娠中の重度の高血圧疾患である.
- これらの状態を管理し,発作を予防するために,抗発作予防は非常に重要です.
- フェニトインは一般的に使用される抗薬です.
研究 の 目的:
- 前出血栓症および出血栓症の患者における抗発作予防のための高用量静脈注射フェニトインナトリウムの有効性と安全性を評価する.
- この患者集団における輸液中のおよび輸液後のプラズマフェニトインレベルをモニタリングするために.
主な方法:
- 静脈内フェニトインナトリウムは高用量輸液 (8-18 mg/kg) として投与されました.
- この研究では,エクラムプシアの患者2名と,中等度から重度のプレエクラムプシアの患者24人が参加しました.
- プラズマフェニトイン濃度は,注入後30分,6時間,12時間および24時間後に測定されました.
主要な成果:
- 主要な母体または新生児の副作用は観察されなかった.
- 血フェニトイン濃度は,すべての患者で30分と6時間後に治療範囲 (7-20 mg/l) の内にとどまった.
- 治療レベルは21人の患者で12時間,第2回投与後の19人の患者で24時間維持された.
結論:
- 高用量の静脈注射フェニトインナトリウムは,子宮内閉塞前症候群と子宮内閉塞における抗震性予防のための安全で効果的な選択肢です.
- この薬は,この産婦人科の集団で治療的な血濃度を達成し,維持します.
- さらなる研究により,最適な投与レジメンと長期的な結果について調べることができます.
関連する概念動画
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

